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Summary 
In vivo adoptive transfer of CD4 + T  helper cell type 1 clones reactive with autologous myelin 
basic protein (MBP) may initiate an inflammatory demyelinating disease of the central nervous 
system called experimental autoimmune encephalomyelitis. Although MBP is also a component 
of peripheral nervous system (PNS) myelin, previous studies have failed to demonstrate inflammation 
in the PNS induced by MBP-reactive T cells. Here, we report on two MBP-specific T cell clones 
that preferentially initiate inflammatory and demyelinating peripheral neuritis when adoptively 
transferred to syngeneic recipients. The MBP epitope recognized by these clones spans the junction 
of exons 6 and 7 and, therefore, is present in the 21- and 18.5-kD but not the 14- and 17-kD 
MBP isoforms, in which exon 5 is spliced to exon 7. The data suggest that MBP may be processed 
and presented differently in the central nervous system and PNS, and they provide evidence for 
MBP as a potential target for autoimmune reactions in the PNS. 
W 
idespread multifocal inflammation and demyelination 
of the peripheral nervous system (PNS) characterize 
both chronic and acute inflammatory demyelinating poly- 
radiculoneuropathies. Indications that these diseases are of 
an autoimmune nature were supported by animal studies of 
experimental autoimmune neuritis (EAN), which can be ex- 
perimentally induced by immunization with peripheral nerve 
tissue in adjuvant (1). Investigations of the neuritogenic com- 
ponents of peripheral nerve demonstrated that EAN can be 
induced by immunization of rats with either the P0 or the 
P2 proteins of peripheral nerve myelin (2,  3). EAN can be 
adoptively transferred to native recipients with CD4 + cells 
specific for either of these two myelin proteins (4,  5). 
In addition to the P0 and P2 proteins, peripheral nerve my- 
elin contains a third major protein,  designated Pl.  The P0 
and P2 proteins are unique to peripheral nerve myelin and 
constitute ",~45-65%  and 2-15%  of PNS myelin proteins, 
respectively (6, 7). In contrast, the P1 protein is identical in 
amino acid sequence to central nervous system (CNS)-derived 
myelin basic protein (MBP) (8, 9).  Despite the presence of 
MBP in the PNS as well as in the CNS, MBP-recognizing 
T cell clones that passively transfer experimental autoimmune 
encephalomyelitis in mice have not been shown to induce 
peripheral nerve inflammation and demyelination (10,  11). 
The relative percentages of MBP in CNS and PNS myelin 
differ dramatically. While MBP accounts for 30-40% of my- 
elin proteins in the CNS, it accounts for only 2-16% of pe- 
ripheral nerve myelin proteins, with v~a'iations depending upon 
the precise location within the PNS (7). Precise quantitative 
and qualitative comparisons of PNS and CNS MBP are fur- 
ther complicated by more recent findings of several MBP iso- 
forms (12-15).  In the fully developed mouse CNS, four iso- 
forms of MBP, with molecular masses of 21.5,  18.5,  17.2, 
and  14 kD,  predominate.  While all  major MBP  isoforms 
present in the CNS are also present in the PNS,  as judged 
by PCtL  amplified cDNA  synthesized from sciatic  nerve 
RNA, their relative quantities in CNS various PNS are not 
known (16). 
MBP does, however; appear to play a role in certain in- 
stances of PNS disease. Inflammatory polyneuropathy has been 
shown, in some patients, to correlate with antibodies to MBP 
(17). Pender et al. have shown demyelination of spinal roots 
after adoptive transfer of MBP-sensitized lymphocytes to Lewis 
rat recipients (18),  although no involvement of dorsal root 
ganglia, spinal nerves, and peripheral nerves was observed. 
We previously characterized encephalitogenic MBP-specific 
T  cell clones from BALB/c mice (19,  20).  12  out  of 14 
I-Aa-restricted clones recognizing an epitope in the 59-76 
peptide of MBP were capable of causing severe autoimmune 
encephalomyelitis upon adoptive transfer into BALB/c re- 
cipients (19). Histologically, severe inflammation and demye- 
lination in the CNS were observed; no evidence of PNS in- 
volvement was found. In contrast, two I-Ea-restricted T cell 
clones recognizing an epitope present in the COOH-terminal 
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cause only moderate clinical and histological signs of disease 
(20).  Here we report that, although the latter two T  cell 
clones induce moderate inflammation in the CNS, they in- 
duce significant PNS disease. The MBP epitope recognized 
by these clones spans  an alternative MBP exon splice site. 
Materials and Methods 
Mice.  Female  BALB/c mice were purchased from Harlan Bio- 
products for Science, Inc. (Indianapolis, IN) and used between the 
ages of 6-10 wk. 
Antigens.  Mouse  MBP peptides 59-76 (HTRTTHYGSLPQK- 
SQHGR), 151-168 (IFKLGGRDSRSGSPMARR),  155-168, and 
111-114/155-168 (RFSWGGRDSRSGSPMARR) were synthesized 
by Dr. Charles Dahl (Harvard Medical School, Boston, MA). 
T Cell Clones.  The derivation and specificity  of MBP-reactive 
BALB/c clones has been previously described (19, 20). Clone A2 
was derived from a BALB/c mouse immunized with MBP peptide 
151-168 and selected in vitro with homologous peptide. 
Assays of Antigen-specific Proliferative Responses and 11-,2.  For 
antigen-specific proliferation, triplicate cultures containing 5  x 
104 cloned T cells were incubated with 5  x  l0  s irradiated (3,000 
R) spleen cells in the presence or absence of Ag as detailed else- 
where (19, 20). Similarly,  production of supematants and Ib2 assays 
were performed as described previously (19). The means of tripli- 
cate cultures are presented. Standard deviations were <20%. 
In Vivo Adoptive Transfer  of l~'sease.  T cell clones were activated 
in vitro for 3 h with irradiated syngeneic spleen cells, 10 t~g/ml 
MBP peptide, and 1I.-2. Cells were harvested, washed, and injected 
intravenously into lightly irradiated (390 R) BALB/c recipients. 
Immediately  after cell injections, and again after 3 d, recipients  were 
injected intravenously with 200 ng purified pertussis toxin (List 
Biological Laboratories, Inc., Campbell, CA). 
Clinical and Histopathological Evaluation.  Mice  were monitored 
daily for clinical signs of disease and scored as follows: 0, no din- 
ical signs; 1, complete tail limpness, incontinence and ruflq_ing of 
fur; 2, limp tail and moderate hind limb weakness; 3, complete 
hind limb paralysis;  4, complete hind limb paralysis and some fore- 
limb weakness; and 5, moribund state. 
For histopathological analysis, tissues from affected mice were 
fixed in Bouin's solution followed  by 10% formalin before embed- 
ding in paraffin. Multiple cross sections of brain and spine, with 
spinal cord in situ, as well as sections of whole legs, were stained 
with hematoxylin and eosin. Replicate sections were stained with 
luxol fast blue and cresyl violet, and with Bodian stain for axons. 
The assignment of a severity  score is on the basis of a semiquantita- 
tive evaluation of the extent of mononuclear cell infiltration and 
of demyelination. 
Results and Discussion 
BALB/c-derived T  cell dories reactive with two distinct 
MBP epitopes were studied for their ability to induce inflam- 
matory and demyelinating disease in syngeneic recipients. All 
clones used in these studies are Thls, secreting IL-2 and IFN-'y 
but not IL-4 after activation (19 and data not shown). 3 d 
after in vitro activation with syngeneic spleen cells and ap- 
propriate peptide antigens,  107 MBP-reactive T  cell clones 
were injected intravenously into lightly irradiated (390-R) 
BALB/c recipients (Table 1). The recipients developed signs 
of disease 7-14 d after transfer. Recipients of clones 1E2 and 
2C2, specific for the COOH-terminal MBP peptide 151-168 
in association with I-E  d, showed ruffling of fur, significant 
and progressive weight loss, complete tail paralysis, and hind 
limb ataxia. Paralysis of a hind leg was observed  in only 1 
out of 11 1E2 recipients,  but not among 13 2C2 recipients. 
These clinical signs appear modest compared with the para- 
plegia and tetraplegia consistently observed upon transfer of 
BALB/c-derived T  cell clones recognizing the MBP 59-76 
peptide  in  association with  I-A  a,  such as  clones 8-4.G6, 
8-7.D8,  and 8-3.E8. 
Histological studies of CNS from recipients  of MBP 151- 
168-specific clones 1E2 or 2C2 revealed only very mild CNS 
disease: Very few inflammatory loci were observed, and there 
was no evidence of demyelination (20 and Table 1). By con- 
trast, recipients of clones recognizing the 59-76 peptide of 
MBP had numerous inflammatory loci accompanied by se- 
vere demyelination in CNS tissue (19 and Table 1). However, 
upon examination of PNS tissue, evidence of significant inflam- 
Table  1.  CNS  versus PNS Eh'sease Induction by Adoptively  Transferred BALB/c  Anti-MBP  T  Cell  Clones 
Histological findings 
CNS  PNS 
MBP  Recipient  Clinical 
Clone  peptide  (No.  mice)  disease  Inflammation  Demyelination  Inflammation  Demyelination 
1E2  151-168  BALB/c (6)  2.0  +  No  + + + +  Yes 
2C2  151-168  BALB/c (3)  2.0  +  No  + + + +  Yes 
8-4.G6  59-76  BALB/c (4)  5.0  + + + +  Yes  -  No 
8-7.D8  59-76  BALB/c (3)  5.0  + + + +  Yes  -  No 
8-3.E8  59-76  BALB/c (3)  5.0  + + + +  Yes  -  No 
107 of the indicated  T cell clones were injected intravenously  into BALB/c recipients 3 d after activation in vitro with the indicated  peptides and 
syngeneic BALB/c  spleen cells. Mice were killed when moribund or by day 21, and tissue sections were evaluated as described. 
588  Autoimmune  Peripheral Neuritis Induced  by MBP-specific  T Cells Figure  1.  Histological sections from recipients of PNS disease-inducing  clones. (A) Longitudinal  section through quadriceps muscle from a BALB/c 
recipient of clone 2C2 (day 26). Many nerves are severely inflamed. Luxol fast blue-cresyl  violet (LFB)  x93. (B) Higher power view of a small nerve 
from A. A few small foal stain with LFB, but most of the nerve has been replaced by inflammatory  cells,  x 373.  (C) Cross  section of cauda equina 
from the same mouse shown in A and B. Here, some roots are partially preserved, but most have undergone partial demyelination. LFB x 373. (D) Cross 
section of a spinal root from a recipient  of clone 1E2 22 d earlier. One portion of the root is demyelinated,  while much of the root is quite normal. 
LFB x 373. (E) Midline dorsal column of lumbar spinal cord from mouse shown in A-C. The meninges around a vein are inflamed, as is the immediately 
underlying white matter where no myelin remains. LFB  x373. (F) Low power view of brain from the mouse in A. There is no evidence of inflammation 
or demyelination.  LFB  x37. 
mation and demyelination was observed  in recipients  of clones 
1E2 and 2C2 but not in recipients of peptide 59-76-reactive 
clones. 
In all recipients of clones 1E2 and 2C2, the most severely 
affected  parts of the nervous system were peripheral nerves 
in the hind leg.  Most nerves were diffusely and densely in- 
589  Abromson-Leeman  et al.  Brief Definitive Report Table  2.  COOH-terminal Amino Acid Sequences of Mouse MBP Peptides Used in This Study 
Exon  7 
Peptide  151  154  155  156  157  158  159  160  161  162  163  164 
151-168  I  L  G  G  R  D  S  R  S  G  S  P 
155-168  G  G  R  D  S  R  S  G  S  P 
Exon  5  Exon  7 
"5/7"*  R  F  S  W  G  G  R  D  S  R  S  G  S  P  M  A  R  R  5/7 
Exon  6 
152  153 
F  K 
Splice 
165  166  167  168  site 
M  A  R  R  6/7 
M  A  R  R  7  only 
* This peptide corresponds  to residues  111-114/155-168  of the  18.5-kD  isoform of mouse MBP but constitutes  the COOH-terminal  18 residues 
of the  14-  and  17.2-kD  isoforms. 
filtrated by mononuclear inflammatory cells,  predominantly 
macrophages, with fewer lymphocytes (Fig. 1, A  and B). Only 
a few scattered  areas of intact myelin remained  (Fig.  1 B). 
Bodian stains of severely inflamed nerves revealed a deficiency 
of axons, suggesting that they had undergone necrosis. More 
proximally,  some  larger  nerves  and  spinal  roots were un- 
affected,  while others were partially  demyelinated (Fig. 1, C 
and D). Examination of many cross sections of spinal cord 
revealed inflammation and partial demyelination in some spinal 
roots and loci of inflammatory cell infiltration in meninges. 
Inflammation  and demyelination  were present in subpial white 
matter as well. All such loci were superficial  and extended 
into the spinal  cord only a short distance  (Fig.  1 E).  Very 
rare small loci of inflammation were observed in the brains 
of a few animals,  but demyelination in the brain was never 
observed  (Fig.  1 F). 
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Figure  2.  Specificity  of peptide-induced  proliferation 
and  IL-2 secretion  by  MBP  COOH-terminal  specific 
BALB/c  T cell clones. Parallel 96-well plates of clones 2C2, 
1E2, or A2 were incubated with the indicated concentra- 
tions of MBP peptides  151-168 (~),  155-168 (-IF),  or 
111-114/155-168 (~)  in the presence of 5  ￿  10S/well 
irradiated BALB/c spleen cells. One set of plates was pulsed 
with [3H]thymidine  for 20-44 h of culture, while super- 
natants of triplicate culture wells were harvested and pooled 
from the second set; these were then assayed for IL-2 con- 
tent using HT-2 cells. Proliferation in the absence of added 
peptides  was 563,  1,902,  and  145 cpm for clones  2C2, 
1E2,  and A2,  respectively.  Proliferation  of HT-2 in the 
absence of added supernatant was 135 cpm. All standard 
deviations  were <20%. 
590  Autoimmune Peripheral Neuritis Induced  by MBP-specific  T  Cells MBP exists predominantly in four different isoforms in 
the adult nervous system (14, 15). In the 14- and 17.2-kD 
isoforms, exon 5 is spliced directly to exon 7. The adult brain 
has over threefold more of the exon 5/7 spliced forms (14 
and 17.2 kD) than 6/7 spliced forms (21 and 18.5 k.D) (12). 
We synthesized a number of peptides of the MBP COOH 
terminus, shown in Table 2, including one corresponding to 
exon 7 only (155-168), one consisting of  4 residues from exon 
6 spliced to exon 7 (151-168, representing the 18 COOH- 
terminal residues of the 21- and 18.5-kD isoforms), and one 
consisting of 4 residues from exon 5 spliced to exon 7 ("5/7"), 
representing the 17.2- and 14-kD isoforms. Epitope mapping 
using this  series of COOH-terminal MBP peptides  shows 
that the MBP epitope recognized by clones 1E2 and 2C2 lies 
within residues 151-168 and requires the junction of exons 
6 and 7. Fig. 2 shows the proliferative responses and the pat- 
terns of IL-2 production by clones 1E2 and 2C2 to the series 
of synthetic COOH-terminal MBP peptides described. These 
data show that proliferative responses of clones 1E2 and 2C2 
to peptide 155-168 (exon 7 only) require 100-fold more pep- 
tide as compared with their responses to 151-168. The re- 
quirement for exon 6 residues for optimal activation of these 
clones is confirmed by the data in  Fig. 2,  showing that, 
without the exon 6 residues, production of IL-2 by clones 
2C2 and 1E2 is not detectable. Furthermore, peptide "5/7" 
(111-114/155-168), representing the COOH-terminal residues 
of the 14-  and  17.2-kD  forms of MBP, was incapable of 
activating clones 1E2 and 2C2 either to proliferate or to pro- 
duce IL-2 (Fig. 2). Responses of A2, a clone which recog- 
nizes a sequence encoded within exon 7 alone and is unaffected 
by flanking sequences beyond the splice site, are included. 
Clone A2 responds equally to peptide 155-168 (exon 7 only) 
or to 155-168 with residues from either exons 5 or 6 on its 
NH2 terminus. Because clone A2 is also I-E  d restricted (data 
not shown), these data confirm that peptide  5/7 is capable 
of binding to, and being presenting by, the relevant class II 
molecule. 
Despite the presence of MBP in peripheral nerve myelin 
(PO, encephalitogenic  MBP-reactive T cell clones have not 
previously  been shown to initiate peripheral nerve disease  when 
adoptively transferred in vivo. Data presented here define a 
murine model of autoimmune peripheral neuritis, in which 
PNS MBP is the predominant target autoantigen for MBP- 
recognizing T  cell clones. 
There are a number of possible non-mutually exclusive 
explanations for the ability of clones 1E2 and 2C2 to induce 
disease primarily in the PNS. Because the epitope for these 
two clones spans an alternative MBP splice site, they appear 
to recognize MBP sequences present only in the 18.5- and 
21-kD isoforms of MBP. In the CNS, the 17.2- and 14-kD 
isoforms, which contain the 5/7 splice site, are approximately 
threefold more abundant (12). Possible quantitative differences 
in MBP isoform composition in the PNS and CNS could, 
at least partially,  account for the preferential retention and 
activation of these clones in the PNS. 
Another possibility is that differential processing of MBP 
by tissue-specific resident APCs may yield different epitopes. 
That different epitopes may be presented is made even more 
likely by the fact that MBP is endogenously synthesized by 
PNS Schwann cells, which have been shown to function as 
APC (21). Moreno et al. reported that qualitatively different 
epitopes of hen egg lysozyme are generated when comparing 
exogenously provided to endogenously synthesized hen egg 
lysozyme (22). Quantitative differences in I-Ed-restricted T 
cell activation by exogenous,  compared with endogenous, 
fl2-microglobulin peptides have also been reported (23). In- 
timately linked with "determinant selection" of epitopes is 
MHC class II expression. Quantitative differences in MHC 
class II expression  on Schwann cells as compared with microglia 
and astrocytes could affect ligand presentation,  particularly 
in the case of the 1E2 and 2C2 ligand,  where the affinity 
between peptide and class II is relatively low (19). Finally, 
unique trafficking and/or homing properties  of these two 
clones may account for induction of PNS disease, although 
preferential retention and focus initiation are probably ulti- 
mately determined by optimal ligand (peptide/MHC) pre- 
sentation. 
In summary, this report provides the first demonstration 
that autoreactive MBP-recognizing T cell clones can prefer- 
entially induce inflammation and demyelination in the PNS. 
The data also highlight the differential recognition of MBP 
epitopes in the CNS and PNS and suggest that functional 
availability of antigenic epitopes is a determining factor in 
expression of autoimmunity. 
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